ABOUT COURSE
This course offers unique perspective of Jornay PM, an extended-release formulation of methylphenidate designed to be taken in the evening to treat attention deficit hyperactivity disorder (ADHD), providing symptom control starting the next morning and lasting throughout the day by increasing dopamine and norepinephrine activity in the brain.
The curriculum covers essential topics for prescribers including:
- Indications
- Dosage and Administration
- Mechanism of Action
- Pharmacokinetics
- Warnings
- Drug Interactions
- Contraindications
- Augmentation Strategies
- Recommended Lab Tests
- Therapeutic Levels
- Overdose Management
- Tapering/Withdrawal
- Use in Special Populations-
- Pregnancy,
- Lactation,
- Renal Impairment,
- Hepatic Impairment,
- Cardiac Impairment,
- Elderly,
- Children and Adolescents.
- AHA Guidelines
- Important pearls based on years of practice.
This course aims to enhance the clinical skills of psychiatric nurse practitioners and other prescribers by providing the knowledge to prescribe and manage Jornay PM therapy effectively and safely.
LEARNING OBJECTIVES
Brand Names & Generic:
- Learn about brand names under which Jornay PM is marketed.
- Learn about different generic names under which Jornay PM is available in the market.
Indications:
- Learn the FDA-approved uses and potential off-label applications of Jornay PM.
- Know the dosages of all potential off-label uses.
Dosage and Administration:
- Understand different medication forms and their administration.
- Implement appropriate dosage and administration guidelines for Jornay PM in various clinical scenarios.
- Learn how to dose Jornay PM correctly and identify usual dosage ranges.
Pharmacological Effects:
- Explore the mechanisms of Jornay PM.
- Understand how Jornay PM works in the brain to treat ADHD and other conditions.
- Discuss the impact of Jornay PM on neurotransmitter levels and brain chemistry.
Pharmacokinetics:
- Absorption: Understand how Jornay PM is absorbed in the body.
- Distribution: Learn about the distribution of Jornay PM in the body.
- Metabolism: Discuss the metabolism of Jornay PM.
- Elimination: Understand how Jornay PM is eliminated from the body.
- Half–life: Know the half-life of Jornay PM and its clinical significance.
Drug Interactions:
- Identify common drug interactions with Jornay PM and strategies for managing them.
- Understand the mechanisms through which these interactions occur.
- Know which medications should be avoided with Jornay PM due to drug interactions.
Common Side Effects:
- Learn about the most common side effects of Jornay PM.
- Understand potential life-threatening side effects and how to manage them.
- Educate patients on what to expect and how to manage side effects.
Contraindications:
- Learn the conditions under which Jornay PM should not be used.
- Understand the reasons why these conditions are contraindicated.
Best Augmenting Combos for Partial Response:
- Learn about the best augmenting combinations for patients with partial response to Jornay PM.
- Discover effective strategies for augmenting Jornay PM therapy.
- Evaluate the efficacy and safety of common augmentation strategies.
Recommended Lab Tests:
- Learn about recommended lab tests for safe and effective monitoring.
- Identify necessary lab tests to monitor patients on Jornay PM.
- Interpret lab results to guide treatment adjustments.
Therapeutic Monitoring:
- Apply strategies for therapeutic monitoring to optimize treatment outcomes.
- Know about the therapeutic blood levels for Jornay PM.
Overdose:
- Understand the signs and symptoms of Jornay PM overdose.
- Recognize early warning signs of overdose and effective management strategies.
Tapering/Withdrawal:
- Apply best practices for tapering and withdrawal of Jornay PM to minimize withdrawal symptoms.
- Follow the best protocols based on decades of clinical practice to safely taper Jornay PM.
- Educate patients on the process and expected symptoms of tapering.
Usage with Special Populations:
- Gain insights into the unique considerations for prescribing Jornay PM to special populations such as pregnancy, lactation, hepatic impairment, renal impairment, cardiac impairment, elderly, and children.
- Tailor Jornay PM dosage for special populations considering their unique needs.
- Understand the risks and benefits of Jornay PM use in these populations.
AHA Guidelines:
- Learn about the guidelines from the American Heart Association regarding safe use of stimulants and labs necessary before the start of treatment.
Important Pearls:
- Learn about essential clinical pearls to enhance practice and ensure patient safety.
- Understand the most important facts about Jornay PM based on decades of clinical practice.
- Apply practical tips and experiences from clinical practice to improve patient outcomes.
